Literature DB >> 10691684

Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring.

L Kirkovsky1, A Mukherjee, D Yin, J T Dalton, D D Miller.   

Abstract

A series of chiral analogues of bicalutamide bearing electrophilic groups (isothiocyanate, N-chloroacetyl, and N-bromoacetyl) on aromatic ring B of the parent molecule were synthesized. These compounds were designed as affinity ligands for the androgen receptor (AR). We prepared the (R)- and (S)-optical isomers of these compounds as pure enantiomers. The AR binding affinities of these compounds were measured in a competitive binding assay with the radiolabeled high-affinity AR ligand, [(3)H]mibolerone. In accordance with our previous results for the enantiomers of bicalutamide, we found that all (R)-isomers demonstrated much higher binding affinity to the AR as compared to their corresponding (S)-isomers. The para-substituted affinity ligands in ring B bound the AR with higher affinities than the corresponding meta-substituted analogues. Oxidation of thioester affinity ligands to their sulfonyl analogues for the para-substituted compounds decreased AR binding affinities and similar modification increased binding affinities for corresponding meta-analogues. The least potent para-substituted sulfonyl compounds had higher AR binding affinities than the most potent meta-substituted sulfonyl compounds. Overall, the para-substituted unoxidized molecules demonstrated the highest AR binding affinity. Subsequent research using AR exchange assays and Scatchard analyses showed that the isothiocyanate affinity ligands (R)-7, (R)-9, and (R)-10 reported herein are the first specific chemoaffinity ligands for the AR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10691684     DOI: 10.1021/jm990027x

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

Review 1.  Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore.

Authors:  Fraser F Fleming; Lihua Yao; P C Ravikumar; Lee Funk; Brian C Shook
Journal:  J Med Chem       Date:  2010-08-30       Impact factor: 7.446

Review 2.  Discovery and therapeutic promise of selective androgen receptor modulators.

Authors:  Jiyun Chen; Juhyun Kim; James T Dalton
Journal:  Mol Interv       Date:  2005-06

3.  Arylisothiocyanato selective androgen receptor modulators (SARMs) for prostate cancer.

Authors:  Dong Jin Hwang; Jun Yang; Huiping Xu; Igor M Rakov; Michael L Mohler; James T Dalton; Duane D Miller
Journal:  Bioorg Med Chem       Date:  2006-07-07       Impact factor: 3.641

4.  Synthesis of irreversibly binding bicalutamide analogs for imaging studies.

Authors:  Vipin A Nair; Suni M Mustafa; Michael L Mohler; Jun Yang; Leonid I Kirkovsky; James T Dalton; Duane D Miller
Journal:  Tetrahedron Lett       Date:  2005-07-11       Impact factor: 2.415

5.  Cesium fluoride and tetra-n-butylammonium fluoride mediated 1,4-N-->O shift of disubstituted phenyl ring of a bicalutamide derivative.

Authors:  Renukadevi Patil; Wei Li; Charles R Ross; Elfi Kraka; Dieter Cremer; Michael L Mohler; James T Dalton; Duane D Miller
Journal:  Tetrahedron Lett       Date:  2006-06-05       Impact factor: 2.415

6.  Synthesis of oxazolidinedione derived bicalutamide analogs.

Authors:  Vipin A Nair; Suni M Mustafa; Michael L Mohler; James T Dalton; Duane D Miller
Journal:  Tetrahedron Lett       Date:  2006-06-05       Impact factor: 2.415

7.  Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators.

Authors:  Casey E Bohl; Zengru Wu; Jiyun Chen; Michael L Mohler; Jun Yang; Dong Jin Hwang; Suni Mustafa; Duane D Miller; Charles E Bell; James T Dalton
Journal:  Bioorg Med Chem Lett       Date:  2008-09-05       Impact factor: 2.823

8.  In vitro and in vivo structure-activity relationships of novel androgen receptor ligands with multiple substituents in the B-ring.

Authors:  Jiyun Chen; Dong Jin Hwang; Kiwon Chung; Casey E Bohl; Scott J Fisher; Duane D Miller; James T Dalton
Journal:  Endocrinology       Date:  2005-09-15       Impact factor: 4.736

9.  Antiandrogen gold nanoparticles dual-target and overcome treatment resistance in hormone-insensitive prostate cancer cells.

Authors:  Erik C Dreaden; Berkley E Gryder; Lauren A Austin; Brice A Tene Defo; Steven C Hayden; Min Pi; L Darryl Quarles; Adegboyega K Oyelere; Mostafa A El-Sayed
Journal:  Bioconjug Chem       Date:  2012-07-12       Impact factor: 4.774

10.  Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators.

Authors:  Craig A Marhefka; Wenqing Gao; Kiwon Chung; Juhyun Kim; Yali He; Donghua Yin; Casey Bohl; James T Dalton; Duane D Miller
Journal:  J Med Chem       Date:  2004-02-12       Impact factor: 7.446

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.